نمایش پرونده ساده آیتم

dc.contributor.authorKhoshbaten, M
dc.contributor.authorZadimani, A
dc.contributor.authorBonyadi, MR
dc.contributor.authorMohammadzadeh, M
dc.contributor.authorGachkar, L
dc.contributor.authorPourhoseingholi, MA
dc.date.accessioned2018-08-26T08:09:18Z
dc.date.available2018-08-26T08:09:18Z
dc.date.issued2011
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/50431
dc.description.abstractBackground: Some studies have indicated a protective role of H. pylori against risk of esophageal squamous cell carcinoma (ESCC). The purpose of this study was to explore this possible relationship in a case-control study. Methods: One hundred consecutive patients diagnosed with ESCC and 100 healthy people were entered with informed consent. All were asked to provide a blood sample and serum immunoglobulin G (IgG) antibodies against HP-CSAs were measured with an enzyme-linked immunosorbent assay (ELISA). Results: There was significant reverse association between H. pylori positivity and tumour development (OR=0.28, 95% CI: 0.15-0.54), but not with a Cag A positive status. Conclusion: Our findings provide further evidence that H. pylori infection decreases the risk of ESCC but that this is not linked to a Cag A positive status.
dc.language.isoEnglish
dc.relation.ispartofASIAN PACIFIC JOURNAL OF CANCER PREVENTION
dc.subjectEsophageal squamous cell carcinoma
dc.subjectH pylori
dc.subjectCag A status
dc.subjectcase-control study
dc.subjectIran
dc.titleHelicobacter Pylori Infection Reduces the Risk of Esophageal Squamous Cell Carcinoma: A Case-Control Study in Iran
dc.typeArticle
dc.citation.volume12
dc.citation.issue1
dc.citation.spage149
dc.citation.epage150
dc.citation.indexWeb of science
dc.citation.URLhttp://journal.waocp.org/?sid=Entrez:PubMed&id=pmid:21517248&key=2011.12.1.149


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم